Common Contracts
3 similar Open Market Sales Agreement contracts by IDEAYA Biosciences, Inc., Recursion Pharmaceuticals, Inc.
OPEN MARKET SALES AGREEMENTSMOpen Market Sales Agreement • January 19th, 2024 • IDEAYA Biosciences, Inc. • Pharmaceutical preparations • New York
OPEN MARKET SALES AGREEMENT1Open Market Sales Agreement • August 8th, 2023 • Recursion Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
Recursion Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell from time to time through Jefferies LLC, as sales agent and/or principal (the “Agent”), shares of the Company’s Class A common stock, par value $0.00001 per share (the “Class A Common Shares”), having an aggregate offering price of up to $300,000,000 on the terms set forth in this sales agreement (this “Agreement”). The Class A Common Shares and the shares of the Company’s Class B common stock, par value $0.00001 per share, are referred to herein as the “Common Stock.”
OPEN MARKET SALES AGREEMENTSMOpen Market Sales Agreement • June 30th, 2023 • IDEAYA Biosciences, Inc. • Pharmaceutical preparations • New York
